Study reveals mechanism involved in rare pediatric brain cancer and points to possible treatment
Milvexian shows potential to reduce risk of ischemic stroke
29 August 2022Attaining sinus rhythm mediates improved outcomes with early rhythm control therapy of atrial fibrillation
29 August 2022Study reveals mechanism involved in rare pediatric brain cancer and points to possible treatment
A study conducted by researchers in Brazil, Australia, Austria and the United States has made significant discoveries about a type of pediatric cancer with no approved drugs for treatment and with a low survival rate. The findings, described in an article published in the journal Neuro-Oncology, pave the way for a search for more specific therapies.
